Prognostic value and therapeutic potential of TREM-1 in Streptococcus pyogenes-induced sepsis

Journal of Innate Immunity

Volumn 5, Issue 6, 2013, Pages 581-590

  Horst, Sarah A ^a   Linnér, Anna ^c   Beineke, Andreas ^b   Lehne, Sabine ^a   Höltje, Claudia ^a   Hecht, Alexander ^a   Norrby Teglund, Anna ^c   Medina, Eva ^a   Goldmann, Oliver ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Prognostic markers; Sepsis; Streptococcal septic shock; Streptococcus pyogenes; Therapeutic intervention; TREM 1

Indexed keywords

TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; EXPERIMENTAL MOUSE; FEMALE; HUMAN; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PHAGOCYTE; PRIORITY JOURNAL; SEPSIS; STREPTOCOCCAL TOXIC SHOCK; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TOXIC SHOCK SYNDROME; UPREGULATION; CLINICAL ARTICLE; GROUP A STREPTOCOCCAL INFECTION; PROGNOSIS; SEPTIC SHOCK; STREPTOCOCCUS PYOGENES INDUCED SEPSIS;

ANIMALS; BIOLOGICAL MARKERS; CELLS, CULTURED; FEMALE; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; INTERLEUKIN-6; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C3H; MICROSCOPY, FLUORESCENCE; PROGNOSIS; RECEPTORS, IMMUNOLOGIC; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPSIS; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888303405     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000348283     Document Type: Article

References (35)

1. Cohen J: The immunopathogenesis of sepsis. Nature 2002; 420: 885-891.
2. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-150.
3. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377.
4. Rivers EP, McIntyre L, Morro DC, Rivers KK: Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ 2005; 173: 1054-1065.
5. Ventetuolo CE, Levy MM: Biomarkers: diagnosis and risk assessment in sepsis. Clin Chest Med 2008; 29: 591-603, vii.
6. Zhang J, She D, Feng D, Jia Y, Xie L: Dynamic changes of serum soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study. BMC Infect Dis 2011; 11: 53.
7. Bouchon A, Dietrich J, Colonna M: Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000; 164: 4991-4995.
8. Bouchon A, Facchetti F, Weigand MA, Colonna M: TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001; 410: 1103-1107.
9. Colonna M, Facchetti F: TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis 2003; 187(suppl 2):S397-S401.
10. Gibot S, Alauzet C, Massin F, Sennoune N, Faure GC, Bene MC, Lozniewski A, Bollaert PE, Levy B: Modulation of the triggering receptor expressed on myeloid cells-1 pathway during pneumonia in rats. J Infect Dis 2006; 194: 975-983.
11. Gibot S, Buonsanti C, Massin F, Romano M, Kolopp-Sarda MN, Benigni F, Faure GC, Bene MC, Panina-Bordignon P, Passini N, Levy B: Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock. Infect Immun 2006; 74: 2823-2830.
12. Lagler H, Sharif O, Haslinger I, Matt U, Stich K, Furtner T, Doninger B, Schmid K, Gattringer R, de Vos AF, Knapp S: TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. J Immunol 2009; 183: 2027-2036.
13. Gibot S, Cravoisy A, Kolopp-Sarda MN, Bene MC, Faure G, Bollaert PE, Levy B: Timecourse of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 2005; 33: 792-796.
14. Gibot S, Kolopp-Sarda MN, Bene MC, Bollaert PE, Lozniewski A, Mory F, Levy B, Faure GC: A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 2004; 200: 1419-1426.
15. Gibot S, Kolopp-Sarda MN, Bene MC, Cravoisy A, Levy B, Faure GC, Bollaert PE: Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004; 141: 9-15.
16. Barati M, Bashar FR, Shahrami R, Zadeh MH, Taher MT, Nojomi M: Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis. J Crit Care 2010; 25: 362e1-362e6.
17. Bopp C, Hofer S, Bouchon A, Zimmermann JB, Martin E, Weigand MA: Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation. Eur J Anaesthesiol 2009; 26: 504-507.
18. Phua J, Koay ES, Zhang D, Lee KH: How well do serum sTREM-1 measurements prognosticate in septic shock? Anaesth Intensive Care 2008; 36: 654-658.
19. Opal SM: Concept of PIRO as a new conceptual framework to understand sepsis. Pediatr Crit Care Med 2005; 6:S55-S60.
20. Jaggi P, Shulman ST: Group A streptococcal infections. Pediatr Rev 2006; 27: 99-105.
21. Lamagni TL, Darenberg J, Luca-Harari B, Siljander T, Efstratiou A, Henriques-Normark B, Vuopio-Varkila J, Bouvet A, Creti R, Ekelund K, Koliou M, Reinert RR, Stathi A, Strakova L, Ungureanu V, Schalen C, Jasir A: Epidemiology of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2008; 46: 2359-2367.
22. Lamagni TL, Neal S, Keshishian C, Powell D, Potz N, Pebody R, George R, Duckworth G, Vuopio-Varkila J, Efstratiou A: Predictors of death after severe Streptococcus pyogenes infection. Emerg Infect Dis 2009; 15: 1304-1307.
23. Darenberg J, Ihendyane N, Sjolin J, Aufwerber E, Haidl S, Follin P, Andersson J, Norrby-Teglund A: Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, doubleblind, placebo-controlled trial. Clin Infect Dis 2003; 37: 333-340.
24. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. JAMA 1993; 269: 390-391.
25. Goldmann O, Hertzen E, Hecht A, Schmidt H, Lehne S, Norrby-Teglund A, Medina E: Inducible cyclooxygenase released prostaglandin E2 modulates the severity of infection caused by Streptococcus pyogenes. J Immunol 2010; 185: 2372-2381.
26. Goldmann O, Sastalla I, Wos-Oxley M, Rohde M, Medina E: Streptococcus pyogenes induces oncosis in macrophages through the activation of an inflammatory programmed cell death pathway. Cell Microbiol 2009; 11: 138-155.
27. Medina E, Goldmann O, Rohde M, Lengeling A, Chhatwal GS: Genetic control of susceptibility to group A streptococcal infection in mice. J Infect Dis 2001; 184: 846-852.
28. Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, Thijs LG, Aarden LA: Increased plasma levels of interleukin-6 in sepsis. Blood 1989; 74: 1704-1710.
29. Pettila V, Hynninen M, Takkunen O, Kuusela P, Valtonen M: Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 2002; 28: 1220-1225.
30. Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, Colonna M, Modlin RL: A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol 2003; 170: 3812-3818.
31. Netea MG, Azam T, Ferwerda G, Girardin SE, Kim SH, Dinarello CA: Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHTLRR (NLR) pattern recognition receptors. J Leukoc Biol 2006; 80: 1454-1461.
32. Haselmayer P, Grosse-Hovest L, von Landenberg P, Schild H, Radsak MP: TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 2007; 110: 1029-1035.
33. El Mezayen R, El Gazzar M, Seeds MC, Mc-Call CE, Dreskin SC, Nicolls MR: Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett 2007; 111: 36-44.
34. Gibot S, Le Renard PE, Bollaert PE, Kolopp-Sarda MN, Bene MC, Faure GC, Levy B: Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock. Intensive Care Med 2005; 31: 594-597.
35. Diao H, Kohanawa M: Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production. Infect Immun 2005; 73: 3745-3748.